Home/Filings/4/0001567619-21-019018
4//SEC Filing

Fu Tao 4

Accession 0001567619-21-019018

CIK 0001704292other

Filed

Oct 28, 8:00 PM ET

Accepted

Oct 29, 5:15 PM ET

Size

8.0 KB

Accession

0001567619-21-019018

Insider Transaction Report

Form 4
Period: 2021-10-28
Fu Tao
DirectorPresident & COO
Transactions
  • Sale

    Ordinary Shares

    2021-10-28$104.49/sh2,065$215,77285,435 total(indirect: See footnote)
  • Sale

    Ordinary Shares

    2021-10-28$105.13/sh7,935$834,20777,500 total(indirect: See footnote)
Holdings
  • Ordinary Shares

    187,668
Footnotes (4)
  • [F1]The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person's spouse, dated June 17, 2021, expires February 28, 2022 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.
  • [F2]Reflects a weighted average sale price of $104.49 per share, at prices ranging from $103.77 to $104.76 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
  • [F3]Reflects a weighted average sale price of $105.13 per share, at prices ranging from $104.87 to $105.40 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
  • [F4]Shares held by Reporting Person's spouse.

Documents

1 file

Issuer

Zai Lab Ltd

CIK 0001704292

Entity typeother

Related Parties

1
  • filerCIK 0001644888

Filing Metadata

Form type
4
Filed
Oct 28, 8:00 PM ET
Accepted
Oct 29, 5:15 PM ET
Size
8.0 KB